The China Alzheimer Report 2022

Peng Yin; Jinlei Qi; Maigeng Zhou; Ying Wang; Chunbo Li; Qiang Huang; Yikang Zhu; Yongbo Hu; Zhihui Wang; Yuan Zhu; Jianping Li; Gang Wang; Yiran Wang; Pengfei Wang; Rujing Ren; Shaohui Lin; Xinya Liu; Ran Tang; Jintao Wang; Xinyi Xie; Shishuang Cui; Xiaoping Yu; Yanyan Huang; Yisong Hu

doi:10.1136/gpsych-2022-100751

General Psychiatry (Feb 2022)

The China Alzheimer Report 2022

Peng Yin,
Jinlei Qi,
Maigeng Zhou,
Ying Wang,
Chunbo Li,
Qiang Huang,
Yikang Zhu,
Yongbo Hu,
Zhihui Wang,
Yuan Zhu,
Jianping Li,
Gang Wang,
Yiran Wang,
Pengfei Wang,
Rujing Ren,
Shaohui Lin,
Xinya Liu,
Ran Tang,
Jintao Wang,
Xinyi Xie,
Shishuang Cui,
Xiaoping Yu,
Yanyan Huang,
Yisong Hu

Affiliations

Peng Yin: 2 National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
Jinlei Qi: 2 National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
Maigeng Zhou: 2 National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
Ying Wang: 4 School of Public Health, Fudan University, Shanghai, China
Chunbo Li: 3 Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Qiang Huang: 1 Department of Neurology and Institute of Neurology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
Yikang Zhu: 3 Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Yongbo Hu: 1 Department of Neurology and Institute of Neurology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
Zhihui Wang: 2 National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
Yuan Zhu: 1 Department of Neurology and Institute of Neurology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
Jianping Li: 1 Department of Neurology and Institute of Neurology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
Gang Wang: 1 Department of Neurology and Institute of Neurology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
Yiran Wang: 3 Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Pengfei Wang: 4 School of Public Health, Fudan University, Shanghai, China
Rujing Ren: 1 Department of Neurology and Institute of Neurology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
Shaohui Lin: 3 Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Xinya Liu: 4 School of Public Health, Fudan University, Shanghai, China
Ran Tang: 1 Department of Neurology and Institute of Neurology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
Jintao Wang: 1 Department of Neurology and Institute of Neurology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
Xinyi Xie: 1 Department of Neurology and Institute of Neurology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
Shishuang Cui: 1 Department of Neurology and Institute of Neurology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
Xiaoping Yu: 1 Department of Neurology and Institute of Neurology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
Yanyan Huang: 6 Department of Geriatrics, Huashan Hospital, Fudan University, Shanghai, China
Yisong Hu: 7 National Survey Research Center, Renmin University of China, Beijing, China

DOI: https://doi.org/10.1136/gpsych-2022-100751
Journal volume & issue: Vol. 35, no. 1

Abstract

Read online

China’s population has rapidly aged over the recent decades of social and economic development as neurodegenerative disorders have proliferated, especially Alzheimer’s disease (AD) and related dementias (ADRD). AD’s incidence rate, morbidity, and mortality have steadily increased to make it presently the fifth leading cause of death among urban and rural residents in China and magnify the resulting financial burdens on individuals, families and society. The ‘Healthy China Action’ plan of 2019–2030 promotes the transition from disease treatment to health maintenance for this expanding population with ADRD. This report describes related epidemiological trends, evaluates the economic burden of the disease, outlines current clinical diagnosis and treatment status and delineates existing available public health resources. More specifically, it examines the public health impact of ADRD, including prevalence, mortality, costs, usage of care, and the overall effect on caregivers and society. In addition, this special report presents technical guidance and supports for the prevention and treatment of AD, provides expertise to guide relevant governmental healthcare policy development and suggests an information platform for international exchange and cooperation.

Published in General Psychiatry

ISSN: 2517-729X (Online)
Publisher: BMJ Publishing Group
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system: Psychiatry
Website: https://gpsych.bmj.com/

About the journal